只使用免费官方源:SEC Forms 3/4/5 结构化内部人申报,以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界,不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量;个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S(公开市场或私下交易),成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-29 2026-07-31 | HCWB HCW Biologics Inc. | Wong Hing C Director,Officer,TenPercentOwner · Chief Executive Officer | 买入(P) | 23,210 | US$2.59 | US$59,997.85 | 125,845 | SEC |
| 2026-05-22 2026-05-27 | HCWB HCW Biologics Inc. | Byam Rebecca Officer · Chief Financial Officer | 买入(P) | 14,235 | US$1.41 | US$20,071.35 | 57,245 | SEC |
| 2026-05-22 2026-05-27 | HCWB HCW Biologics Inc. | GARRETT SCOTT T Director | 买入(P) | 177,936 | US$1.41 | US$250,889.76 | 203,441 | SEC |
| 2026-05-22 2026-05-27 | HCWB HCW Biologics Inc. | Wong Hing C Director,Officer,TenPercentOwner · Chief Executive Officer | 买入(P) | 113,879 | US$1.41 | US$160,569.39 | 615,790 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| HCWB | 10,122 | 60 | 22,850.1911 | 44.30% | B, Q, N |